Tumorigenicity risk of iPSCs in vivo: nip it in the bud.
- Published in:
- Precision Clinical Medicine, 2022, v. 5, n. 1, p. 1, doi. 10.1093/pcmedi/pbac004
- By:
- Publication type:
- Article
Works matching IS 20965303 AND DT 2022 AND VI 5 AND IP 1
Results: 6
1
2
Infantile hepatic hemangiomas: looking backwards and forwards.
- Published in:
- Precision Clinical Medicine, 2022, v. 5, n. 1, p. 1, doi. 10.1093/pcmedi/pbac006
- By:
- Publication type:
- Article
3
Novel directions of precision oncology: circulating microbial DNA emerging in cancer-microbiome areas.
- Published in:
- Precision Clinical Medicine, 2022, v. 5, n. 1, p. 1, doi. 10.1093/pcmedi/pbac005
- By:
- Publication type:
- Article
4
Precision medicine: a few thoughts from 2022.
- Published in:
- Precision Clinical Medicine, 2022, v. 5, n. 1, p. 1, doi. 10.1093/pcmedi/pbac003
- By:
- Publication type:
- Article
5
Recent advances in single-cell sequencing technologies.
- Published in:
- Precision Clinical Medicine, 2022, v. 5, n. 1, p. 1, doi. 10.1093/pcmedi/pbac002
- By:
- Publication type:
- Article
6
Multivariate competing endogenous RNA network characterization for cancer microRNA biomarker discovery: a novel bioinformatics model with application to prostate cancer metastasis.
- Published in:
- Precision Clinical Medicine, 2022, v. 5, n. 1, p. 1, doi. 10.1093/pcmedi/pbac001
- By:
- Publication type:
- Article